Evidence map›Paper›PMID 37560344›Full record

ArticleWorld journal of oncology2023

A Case of

Masanori Oshi, Akimitsu Yamada, Aki Kimura, Toshiaki Kataoka, Noritoshi Kobayashi, Yasushi Ichikawa, Shoji Yamanaka, Satoshi Fujii, Itaru Endo

Abstract readCase Reports
In one paragraph

Article in World journal of oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masanori OshiDepartment of Breast Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Akimitsu YamadaDepartment of Breast Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Aki KimuraDepartment of Breast Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Toshiaki KataokaDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Noritoshi KobayashiDepartment of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yasushi IchikawaDepartment of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Shoji YamanakaDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Satoshi FujiiDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Itaru EndoDepartment of Breast Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the popularization of cancer screening and an improvement in treatment over the last two decades, multiple primary malignant neoplasms (MPMNs) have been increasingly reported. We report a patient who developed metachronous MPMNs in the breast, the endometrium, and the pancreas over a period of 13 years. A 42-year-old woman was first diagnosed with breast cancer and underwent breast-conserving surgery with adjuvant radiation therapy and endocrine therapy. Four years after breast surgery, she was diagnosed with endometrial cancer and underwent a laparoscopic modified radical hysterectomy with bilateral oophorectomy with pelvic lymph node dissection followed by adjuvant chemotherapy. However, there was peritoneal dissemination of endometrial cancer 1 year after surgery, which could be removed laparoscopically followed by adjuvant chemotherapy. Ten years after breast cancer surgery, pleural metastasis of breast cancer was diagnosed and treated by endocrine therapy. Thirteen years after breast cancer surgery, a pancreatic tumor with multiple liver masses emerged. It was difficult to diagnose whether primary or metastasis cancer by the results of the pathological analysis. Finally, we diagnosed primary pancreatic cancer with liver metastasis by clinical examination with the

Indexed as

BRCA mutationBreast cancerMultiple primary malignant neoplasmsPancreatic cancer

Identifiers

PMID37560344
PMCPMC10409560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.